Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Ultragenyx Pharmaceutical Inc. (RARE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Horn Howard (CFO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 80,366 shares
@ $0
Granted 140,469 options to buy
@ $35.68, valued at
$5M
|
|
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 585 shares
@ $46.76, valued at
$27.4k
|
|
| 06/09/2023 |
4
| Ray Amrit (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/09/2023 |
4
| Fust Matthew K (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Disposed/sold 3,300 shares
@ $51.82, valued at
$171k
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/09/2023 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Sold 1,485 shares
@ $51.65, valued at
$76.7k
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/09/2023 |
4
| SULIMAN SHEHNAAZ (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/09/2023 |
4
| NARACHI MICHAEL (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/09/2023 |
4
| Dunsire Deborah (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/09/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 05/19/2023 |
4
| Pinion John Richard (See Remarks) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 2,012 shares
@ $50, valued at
$100.6k
|
|
| 05/10/2023 |
4
| Huizenga Theodore Alan (SVP, Chief Accounting Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Exercised 3,000 options to buy
@ $21, valued at
$63k
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Crombez Eric (EVP and Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 4,658 shares
@ $0
Granted 8,362 options to buy
@ $44.03, valued at
$368.2k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2023 |
4
| Bedrosian Camille L (EVP and Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Sold 3,881 shares
@ $45.25, valued at
$175.6k
|
|
| 03/03/2023 |
4
| Parschauer Karah Herdman (EVP and Chief Legal Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Granted 22,000 shares
@ $0
Sold 3,161 shares
@ $45.25, valued at
$143k
Granted 39,400 options to buy
@ $45.65, valued at
$1.8M
|
|
| 03/03/2023 |
4
| Kassberg Thomas Richard (CBO & EVP) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Granted 22,000 shares
@ $0
Sold 1,968 shares
@ $45.27, valued at
$89.1k
Disposed/sold 3,394 shares
@ $45.65, valued at
$154.9k
Granted 39,400 options to buy
@ $45.65, valued at
$1.8M
|
|
| 03/03/2023 |
4
| Huizenga Theodore Alan (SVP, Chief Accounting Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 7,590 shares
@ $0
Sold 100 shares
@ $45.65, valued at
$4.6k
Disposed/sold 1,333 shares
@ $45.65, valued at
$60.9k
Granted 10,120 options to buy
@ $45.65, valued at
$462k
|
|
| 03/03/2023 |
4
| Huang Dennis Karl (See Remarks) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Granted 22,000 shares
@ $0
Sold 389 shares
@ $45.65, valued at
$17.8k
Disposed/sold 10,599 shares
@ $45.65, valued at
$483.8k
Granted 39,400 options to buy
@ $45.65, valued at
$1.8M
|
|
| 03/03/2023 |
4
| Pinion John Richard (See Remarks) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Granted 22,000 shares
@ $0
Sold 3,755 shares
@ $45.26, valued at
$170k
Disposed/sold 4,014 shares
@ $45.65, valued at
$183.2k
Granted 39,400 options to buy
@ $45.65, valued at
$1.8M
|
|
| 03/03/2023 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 8,716 shares
@ $0
Granted 46,200 shares
@ $0
Paid exercise price by delivering 16,140 shares
@ $45.65, valued at
$736.8k
Granted 83,500 options to buy
@ $45.65, valued at
$3.8M
|
|
| 03/03/2023 |
4
| Harris Erik (EVP & Chief Commercial Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Granted 22,000 shares
@ $0
Sold 3,664 shares
@ $45.25, valued at
$165.8k
Granted 39,400 options to buy
@ $45.65, valued at
$1.8M
|
|
| 03/02/2023 |
4
| Huizenga Theodore Alan (SVP, Chief Accounting Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 639 shares
@ $43.4, valued at
$27.7k
|
|
| 01/03/2023 |
4
| KAKKIS EMIL D (President & CEO) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 19,582 shares
@ $45.57, valued at
$892.4k
|
|
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 1,629 shares
@ $40.16, valued at
$65.4k
|
|
| 10/14/2022 |
4
| Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 3,484 shares
@ $38.22, valued at
$133.2k
|
|
| 09/19/2022 |
4
| Dier Mardi (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 09/08/2022 |
4
| Huizenga Theodore Alan (SVP, Chief Accounting Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,000 shares
@ $0 |
|
| 06/29/2022 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,300 shares
@ $0
Granted 6,245 options to buy
@ $60.57, valued at
$378.3k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|